Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dT booster immune response in adults with anti-interferon-gamma autoantibody immunodeficiency
TCTR20190422001Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Apr 2019
- Countries
- 1
01
Overview
Open-label trial in Anti-interferon-gamma autoantibody syndrome (AIGA) (2 arms), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Immune response to diphtheria and tetanus toxoid. Started Apr 2019; status: recruiting.
02
Conditions
Anti-interferon-gamma autoantibody syndrome (AIGA)
Beyond the preview
Go deeper on TCTR20190422001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190422001.